• Evaluación de los efectos de estrógenos sobre la hemostasia y la respuesta inflamatoria.
• Estudio del perfil hemostático, vascular y metabólico de anticonceptivos, in vivo e in vitro.

• Ovariectomía.
• Tratamientos farmacológicos.
• Pruebas de coagulación (generales y específicas).
• ELISAS.
• Extracción de RNA y DNA.
• Cultivo celular.

Dra. Ruth Jaimez Melgoza
Profesor Títular

Dra. Maribel Soto Nuñez
Técnico Académico Asociado

• Antiallodynic Activity of Ceftriaxone and Clavulanic Acid in Acute Administration is Associated with Serum TNF-∞ Modulation and Activation of Dopaminergic and Opioidergic Systems.
• Inhibitory effect of ethinylestradiol on coagulation factors in rats.
• In vivo and in vitro estrogenic profile of 17b-amino-1,35(1O) estratrien-3-ol.
• Ovariectomy differential influence on sorne hemostatic markers of mice and rats.
• In vivo profile of the anticoagulant effect or 17í3-amino-1,3,5(1O)- estratrien-3-ol.
• Gender differences in response to chronic treatment with 17𝛃-oestradiol and 17𝛃-aminoestroqen pentolame on hemostasis in rats.
• Spagl6. an axonernal central apparatus gene, encodes a male germ cell nuclear speckle protein that regulates SPAG16. mRNA expression.
• Antimetastatic antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
• Gender and inter-species influence on screening coagulation tests of rats and mice.
• Estrogenic effects of 17𝛃-aminoestrogens assessed in uteri of rats and mice. Eur J Pharmacol.
• Contrastinq effects of estradiol and 17𝛃-aminoestrogens on blood clotting time in rats and mice.
• Morphometric analysis of mice uteri treated with the preservatives methyl. ethyl. propyl, and butylparaben.
• Confirmation of the C-17 stereochemistry of Pentolame by single crystal X-ray analysis of its monohydrate.